Estrogens, BRCA1, and breast cancer

Cancer Research

Volumn 60, Issue 18, 2000, Pages 4993-5001

  Hilakivi Clarke, L ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL TRANSFORMATION; DNA DAMAGE; ESTROGEN BLOOD LEVEL; FEMALE; GENE ACTIVATION; GENE MUTATION; GENETIC STABILITY; HUMAN; METHYLATION; NONHUMAN; ONCOGENE; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMAL; BREAST NEOPLASMS; ESTROGENS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HUMAN; MAMMARY NEOPLASMS, EXPERIMENTAL; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0034665412     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Breast cancer: Cause and prevention
2. The risk of breast cancer following reproductive surgery
3. Menstrual factors and risk of breast cancer
4. Breast cancer risk associated with gynecologic surgery and indications for such surgery
5. Hysterectomy, oophorectomy in premenopause, and risk of breast cancer
6. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta-analysis of quality-adjusted survival
7. Oral contraceptives and breast cancer: Review and meta-analysis
8. Breast cancer and hormonal contraceptives: Collaborative re-analysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
9. Breast cancer and depot-medroxyprogesterone acetate: A multinational study
10. Depot medroxyprogesterone (Depovera) and risk of breast cancer
11. Body size at different periods of life and breast cancer risk
12. Dual effects of weight and weight gain on breast cancer risk
13. Familial clustering of obesity and breast cancer
14. Body size in different periods of life and breast cancer risk in post-menopausal women
15. Risk factors for breast cancer in Chinese women in Shanghai
16. Menstrual factors in relation to breast cancer risk
17. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women
18. Body size indices and breast cancer risk before and after menopause
19. Is estradiol a genotoxic mutagenic carcinogen?
20. A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring
21. Biological and molecular bases of mammary carcinogenesis
22. Hypothesis: Does breast cancer originate in utero?
23. In utero and early life exposures in relation to risk of breast cancer
24. Age at first birth and breast cancer
25. Adolescence and breast carcinoma risk
26. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues
27. Hormone-dependent regulation of BRCA1 in human breast cancer cells
28. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen
29. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells
30. What's new in preventing and treating osteoporosis?
31. Efficacy and safety of estrogen/androgen therapy. Menopausal symptoms, bone, and cardiovascular parameters
32. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
33. Various actions of oestrogens on the vascular system
34. Estrogen and cognitive functioning in women
35. Oestrogen and mental state
36. Estrogen-serotonin interactions: Implications for affective regulation
37. The endocrinology of breast cancer
38. Endocrine influences on the mammary gland
39. Susceptibility of the mammary gland to carcinogenesis: Differentiation of the mammary gland as determinant of tumor incidence and type of lesion
40. BRCA1 mutations in primary breast and ovarian carcinomas
41. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
42. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in the mammary epithelial cells
43. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
44. BRCA1 is a cell-cycle regulated nuclear phosphoprotein
45. BRCA1 required for transcription-coupled repair of oxidative DNA damage
46. Association of BRCA1 with Rad51 in mitotic and meiotic cells
47. BRCA1 physically associates with p53 and stimulates its transcriptional activity
48. BRCA1, BRCA2 and their possible function in DNA damage response
49. Regulation of BRCA1 expression by the Rb-E2F pathway
50. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1 mediated cell growth in suspension
51. Arrest of the cell cycle by the tumour suppressor BRCA1 requires the CDK-inhibitor p21(Waf1/Cip1)
52. BRCA1 expression is not directly responsive to estrogen
53. BRCA1 expression levels predict distant metastasis of sporadic breast cancers
54. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: Correlation with disease characteristics
55. BRCA1 inhibition of estrogen receptor signalling in transfected cells
56. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
57. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts
58. Growth retardation and tumor inhibition by BRCA1
59. Familial breast cancer
60. Somatic mutations in the BRCA1 gene in Chinese sporadic breast cancer and ovarian cancer
61. Evidence for involvement of BRCA1 in sporadic breast cancer carcinomas
62. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families
63. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased mRNA in sporadic breast cancer cells
64. Tumor-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer
65. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
66. Aberrant subcellular localization of BRCA1 in breast cancer
67. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors
68. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region
69. Expression of BRCA1 and BRCA2 in normal and neoplastic cells
70. p53 Mutations in Brca1-associated familial breast cancer
71. Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
72. Inhibition of BRCA1 expression by benzo[a]pyrene and its diol epoxide
73. Molecular effects of genistein on estrogen receptor mediated pathways
74. Soybean phytoestrogen intakecancer risk
75. Influence of genistein and daidzein on BRCA1 protein levels in human breast cancer cell lines
76. Effect of neonatally administered estrogen and prolactin on normal and neoplastic mammary growth and serum estradiol-17 level in rats
77. Chemoprevention of N-nitro-N-methylurea-induced mammary cancers by pretreatment with 17β-estradiol and progesterone
78. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats
79. The role of DNA hypermethylation in human neoplasia
80. DNA methylation, heterocromatin and epigenetic carcinogens
81. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor
82. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
83. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
84. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes
85. Smoking induces increased androgen levels in early post-menopausal women
86. The antiestrogenic effect of cigarette smoking in women
87. Cigarette smokingurinary estrogens
88. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q
89. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
90. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers
91. Pregnancy and risk of breast cancer in carriers of BRCA1 and BRCA2
92. Interaction between a family history of breast cancer and relative weight at age 12 with breast cancer risk in a historical cohort of 426 families
93. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
94. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
95. Prospective study of relative weight and risk of breast cancer: The Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989
96. Menopausal estrogensbreast cancer
97. Tissue structure, nuclear organization, and gene expression in normal and malignant breast
98. Alterations in mammary gland development following neonatal exposure to estradiol, transforming growth factor α, and estrogen receptor antagonist ICI 182,780
99. Comparative study of human and rat mammary tumorigenesis
100. Toward a unified concept of mammary carcinogenesis
101. Architectural pattern of the normal and cancerous breast under the influence of parity
102. Pregnancy
103. Mechanisms of high maternal fat intake during pregnancy on increased breast cancer risk in female rodent offspring
104. Weight percentile at birth. II. Prediction by endocrinological and sonographic measurements
105. Birthweight as a risk factor for breast cancer
106. Perinatal factors and risk of breast cancer
107. Effect of twinship on incidence of cancer of the testis, breast, and other sites (Sweden)
108. Twinship and risk of postmenopausal breast cancer
109. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shangai, China) of breast cancer
110. Perinatal characteristics and adult mammographic patterns
111. Mammographic parenchymal patterns: A marker of breast cancer risk
112. Incidence, growth and oestradiol-receptor levels of 7,12-dimethylbenz(alpha) anthracene-induced mammary tumors in rats: Effects of neonatal sex steroids and oestradiol implants
113. Estrogen-associated defects in rodent mammary gland development
114. Consumption of a high-fat diet during pregnancy alters estrogen receptor content, protein kinase C activity and morphology of mammary gland in the mother and her female offspring
115. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
116. BRCA-associated breast cancer in young women
117. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
118. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse
119. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the eff cylinder in early postimplantation development
120. Biological functions of the BRCA1 and BRCA2 proteins
121. Conditional knockout of BRCA1 in mammary epithelial cells results blunted ductal morphogenesis and tumor formation
122. Cloning, genetic mapping and expression studies of the rat Brca1 gene
123. Database of p53 gene somatic mutations in human tumors and cell lines
124. Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas
125. p53 Mutations increase resistance to ionizing radiation
126. Gatekeepers and caretakers
127. Estradiol regulates tumor growth by influencing p53 and bcl-2 expression in human endometrial adenocarcinomas grown in nude mice
128. Estrogen-induced proto-oncogene and suppressor gene expression in the hamster kidney: Significance for estrogen carcinogenesis
129. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line
130. Mutation analysis in the BRCA2 gene in primary breast cancers
131. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families
132. Developmental expression of Brca2 colocalizes with Brca1 and is associated with differentiation of multiple tissues
133. Dietsex hormone metabolism
134. Dietary fat and fiber in relation to risk of breast cancer
135. Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: Results of a pilot study
136. Physical activity and breast cancer risk in a cohort of young women